Overview

Three Times Daily Dosing of UT-15C

Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetics of three-times daily dosing of UT-15C in healthy volunteers
Phase:
Phase 1
Details
Lead Sponsor:
United Therapeutics
Treatments:
Treprostinil